LONA
NASDAQLeonaBio Inc.
$8.32-0.18 (-2.12%)
News25/Ratings2
Price$8.32+1.94 (+30.41%)
2026-01-212026-04-24
News · 26 weeks410%
2025-11-022026-04-26
Mix3990d
- Insider17(44%)
- SEC Filings15(38%)
- Other4(10%)
- Analyst2(5%)
- Leadership1(3%)
Latest news
25 items- PRLeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast CancerManagement to be Joined by Two Clinical Leaders in the Breast Cancer Field Expected to Complete Enrollment in Ongoing ELAINE-3 Phase 3 Registrational Study of Lasofoxifene in Metastatic Breast Cancer in 4Q26 with Data Expected in 2H27 Webinar Event on Wednesday, April 29, 2026, at 12:00 p.m. ET BOTHELL, Wash., April 23, 2026 (GLOBE NEWSWIRE) -- LeonaBio, Inc. (NASDAQ:LONA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that it will host a virtual Key Opinion Leader event with two leading physician experts in the breast cancer field to discuss the current and evolving treatment la
- PRIndependent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio's DataBOTHELL, Wash., April 21, 2026 (GLOBE NEWSWIRE) -- LeonaBio, Inc. (NASDAQ:LONA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, attended the American Association for Cancer Research Annual Meeting 2026 (AACR26), where independent researchers at Virginia Commonwealth University's Massey Comprehensive Cancer Center presented nonclinical data on lasofoxifene, including its potential for a bone protective role in metastatic breast cancer.1 "We are delighted to learn the findings of this independent research at AACR26, attended by an audience of the world's leading oncology researchers. We believe these
- INSIDERSEC Form 4 filed by Panzara Michael A.4 - LeonaBio, Inc. (0001620463) (Issuer)
- INSIDERSEC Form 4 filed by Church Kevin4 - LeonaBio, Inc. (0001620463) (Issuer)
- INSIDERSEC Form 4 filed by Kosacz Barbara4 - LeonaBio, Inc. (0001620463) (Issuer)
- INSIDERSEC Form 4 filed by Pickering Grant4 - LeonaBio, Inc. (0001620463) (Issuer)
- INSIDERSEC Form 4 filed by Romano Kelly A4 - LeonaBio, Inc. (0001620463) (Issuer)
- INSIDERSEC Form 4 filed by Johnson James A4 - LeonaBio, Inc. (0001620463) (Issuer)
- INSIDERSEC Form 4 filed by Edelman Joseph4 - LeonaBio, Inc. (0001620463) (Issuer)
- INSIDERSEC Form 4 filed by San Martin Javier4 - LeonaBio, Inc. (0001620463) (Issuer)
- INSIDERSEC Form 4 filed by Fluke John M Jr4 - LeonaBio, Inc. (0001620463) (Issuer)
- INSIDERSEC Form 4 filed by Worthington Mark4 - LeonaBio, Inc. (0001620463) (Issuer)
- INSIDERSEC Form 4 filed by Renninger Robert4 - LeonaBio, Inc. (0001620463) (Issuer)
- INSIDERSEC Form 4 filed by Litton Mark James4 - LeonaBio, Inc. (0001620463) (Issuer)
- SECSEC Form EFFECT filed by LeonaBio Inc.EFFECT - LeonaBio, Inc. (0001620463) (Filer)
- SECSEC Form EFFECT filed by LeonaBio Inc.EFFECT - LeonaBio, Inc. (0001620463) (Filer)
- SECSEC Form 424B3 filed by LeonaBio Inc.424B3 - LeonaBio, Inc. (0001620463) (Filer)
- SECSEC Form 424B3 filed by LeonaBio Inc.424B3 - LeonaBio, Inc. (0001620463) (Filer)
- SECSEC Form S-8 filed by LeonaBio Inc.S-8 - LeonaBio, Inc. (0001620463) (Filer)
- SECSEC Form S-8 filed by LeonaBio Inc.S-8 - LeonaBio, Inc. (0001620463) (Filer)
- SECAmendment: SEC Form S-1/A filed by LeonaBio Inc.S-1/A - LeonaBio, Inc. (0001620463) (Filer)
- SECAmendment: SEC Form S-1/A filed by LeonaBio Inc.S-1/A - LeonaBio, Inc. (0001620463) (Filer)
- SECSEC Form 10-K filed by LeonaBio Inc.10-K - LeonaBio, Inc. (0001620463) (Filer)
- SECAmendment: LeonaBio Inc. filed SEC Form 8-K: Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement8-K/A - LeonaBio, Inc. (0001620463) (Filer)
- SECLeonaBio Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - LeonaBio, Inc. (0001620463) (Filer)
LONA FAQ
6 questionsWhere does LONA stock trade?
LeonaBio Inc. (LONA) is listed on NASDAQ.What sector and industry is LONA in?
LeonaBio Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did LeonaBio Inc. go public?
LeonaBio Inc. (LONA) completed its IPO in 2020.What are analysts saying about LONA?
LeonaBio Inc. has had 2 recent analyst actions on file. The most recent action was from Cantor Fitzgerald: Overweight on 2026-02-26. Recent price targets cluster around $1000.00.What companies are similar to LONA?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), BIIB (Biogen Inc.), RVMD (Revolution Medicines Inc.). Compare LONA side-by-side with any of them on Quantisnow.How can I track LONA on Quantisnow?
Quantisnow aggregates LeonaBio Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow LONA to receive live email and push alerts on every new disclosure.